Cargando…

Decreased MYC-associated factor X (MAX) expression is a new potential biomarker for adverse prognosis in anaplastic large cell lymphoma

MYC-associated factor X (MAX) is a protein in the basic helix-loop-helix leucine zipper family, which is ubiquitously and constitutively expressed in various normal tissues and tumors. MAX protein mediates various cellular functions such as proliferation, differentiation, and apoptosis through the M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamashita, Takahisa, Higashi, Morihiro, Momose, Shuji, Adachi, Akiko, Watanabe, Toshiki, Tanaka, Yuka, Tokuhira, Michihide, Kizaki, Masahiro, Tamaru, Jun-ichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316730/ https://www.ncbi.nlm.nih.gov/pubmed/32587329 http://dx.doi.org/10.1038/s41598-020-67500-w

Ejemplares similares

CD24 is a surrogate for ‘immune‐cold’ phenotype in aggressive large B‐cell lymphoma
por: Higashi, Morihiro, et al.
Publicado: (2022)

Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center‐derived B‐cell lymphomas
por: Tanaka, Yuka, et al.
Publicado: (2020)

Rapid deterioration of intravascular large B-cell lymphoma with mass formation in the trigeminal nerve and multiple organ infiltration: An autopsy case report
por: Tanaka, Yuka, et al.
Publicado: (2021)

Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders
por: Tokuhira, Michihide, et al.
Publicado: (2019)

An infected thoracoabdominal aortic aneurysm mimicking the symptoms of urinary tract infection: A case report
por: Yamashita, Takahisa, et al.
Publicado: (2017)

Retroperitoneal Cystic Nodal Metastasis of Renal Cell Carcinoma
por: Yamashita, Takahisa, et al.
Publicado: (2018)

EBV-positive mucocutaneous ulcer arising in methotrexate-treated rheumatoid arthritis patients: a clinicopathological study of 12 cases with analysis of PD-L1 expression
por: Sawada, Keisuke, et al.
Publicado: (2023)

The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders
por: Tokuhira, Michihide, et al.
Publicado: (2020)

Better method for detection of CD30: Immunohistochemistry or flow cytometry?
por: Higashi, Morihiro, et al.
Publicado: (2021)

Co-existence of acute myeloid leukemia with multilineage dysplasia and Epstein-Barr virus-associated T-cell lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report
por: Tokuhira, Michihide, et al.
Publicado: (2009)

Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant setting
por: Momose, Shuji, et al.
Publicado: (2019)

Restoration of Decreased T Helper 1 and CD8+ T Cell Subsets Is Associated With Regression of Lymphoproliferative Disorders Developed During Methotrexate Treatment
por: Saito, Shuntaro, et al.
Publicado: (2018)

Anaplastic multiple myeloma with MYC rearrangement
por: Ichikawa, Satoshi, et al.
Publicado: (2021)

TM-233, a novel analog of 1′-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities
por: Sagawa, Morihiko, et al.
Publicado: (2015)

Max deletion destabilizes MYC protein and abrogates Eµ-Myc lymphomagenesis
por: Mathsyaraja, Haritha, et al.
Publicado: (2019)

Mnt–Max to Myc–Max complex switching regulates cell cycle entry
por: Walker, William, et al.
Publicado: (2005)

MYC-Associated Factor MAX is a Regulator of the Circadian Clock
por: Blaževitš, Olga, et al.
Publicado: (2020)

Brentuximab vedotin for refractory anaplastic lymphoma kinase-negative anaplastic large cell lymphoma in leukemic phase with RUNX3 overexpression
por: Yamashita, Yusuke, et al.
Publicado: (2020)

A selective high affinity MYC-binding compound inhibits MYC:MAX interaction and MYC-dependent tumor cell proliferation
por: Castell, Alina, et al.
Publicado: (2018)

The EUTOS long‐term survival score predicts disease‐specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice‐based cohort
por: Sato, Eriko, et al.
Publicado: (2020)

Visualization of the Activity of Rac1 Small GTPase in a Cell
por: Higashi, Morihiro, et al.
Publicado: (2010)

MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner
por: Castell, Alina, et al.
Publicado: (2022)

Oesophageal adenocarcinoma is associated with a deregulation in the MYC/MAX/MAD network
por: Boult, J K R, et al.
Publicado: (2008)

In vivo quantification and perturbation of Myc-Max interactions and the impact on oncogenic potential
por: Raffeiner, Philipp, et al.
Publicado: (2014)

Metastatic Infiltration of Anaplastic Carcinoma of the Pancreas Into the Portal Venous System: A Masquerading Cause of Expansive Portal Venous Thrombosis
por: Hirakawa, Yuka, et al.
Publicado: (2021)

A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expression
por: Holmes, Austin G., et al.
Publicado: (2022)

Functional Myc-Max heterodimer is required for activation-induced apoptosis in T cell hybridomas
Publicado: (1994)

Direct inhibition of c-Myc-Max heterodimers by celastrol and celastrol-inspired triterpenoids
por: Wang, Huabo, et al.
Publicado: (2015)

Design and Characterization of pMyc/pMax Peptide-Coupled Gold Nanosystems for Targeting Myc in Prostate Cancer Cell Lines
por: Longoria-García, Samuel, et al.
Publicado: (2023)

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors
por: Nishiyama-Fujita, Yuriko, et al.
Publicado: (2022)

True anaplastic oligoastrocytoma with dual genotype: illustrative case
por: Mizuno, Reina, et al.
Publicado: (2022)

Alectinib for relapsed or refractory anaplastic lymphoma kinase‐positive anaplastic large cell lymphoma: An open‐label phase II trial
por: Fukano, Reiji, et al.
Publicado: (2020)

Myc/Max dependent intronic long antisense noncoding RNA, EVA1A-AS, suppresses the expression of Myc/Max dependent anti-proliferating gene EVA1A in a U2 dependent manner
por: Niehus, Svenja E., et al.
Publicado: (2019)

RUNX3 inactivates oncogenic MYC through disruption of MYC/MAX complex and subsequent recruitment of GSK3β-FBXW7 cascade
por: Oei, Vincent, et al.
Publicado: (2023)

Differential expression of myc, max and RB1 genes in human gliomas and glioma cell lines.
por: Hirvonen, H. E., et al.
Publicado: (1994)

Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain
por: Crouch, D. H., et al.
Publicado: (2005)

The Max b-HLH-LZ Can Transduce into Cells and Inhibit c-Myc Transcriptional Activities
por: Montagne, Martin, et al.
Publicado: (2012)

Sequence-specific DNA binding by MYC/MAX to low-affinity non-E-box motifs
por: Allevato, Michael, et al.
Publicado: (2017)

MYC–MAX heterodimerization is essential for the induction of major zygotic genome activation and subsequent preimplantation development
por: Yamamoto, Takuto, et al.
Publicado: (2023)

The balance of two opposing factors Mad and Myc regulates cell fate during tissue remodeling
por: Okada, Morihiro, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_grdrre0bkmfv9aq6k24s7m1veq